Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of a pro-healing stent in an animal model of early neoatherosclerosis.
Nicol P, Lutter C, Bulin A, Castellanos MI, Lenz T, Hoppmann P, Lahmann AL, Colleran R, Euller K, Steigerwald K, Neubauer S, Rechenmacher F, Ludwig BS, Weinmüller M, Kerch G, Guo L, Cheng Q, Acampado E, Koppara T, Kessler H, Joner M. Nicol P, et al. Among authors: lenz t. Sci Rep. 2020 May 19;10(1):8227. doi: 10.1038/s41598-020-64940-2. Sci Rep. 2020. PMID: 32427835 Free PMC article.
Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus : Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial.
Koch T, Lenz T, Joner M, Xhepa E, Koppara T, Wiebe J, Coughlan JJ, Aytekin A, Ibrahim T, Kessler T, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Kufner S; Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus- Eluting Stents (ISAR-TEST 5) Investigators. Koch T, et al. Among authors: lenz t. Clin Res Cardiol. 2021 Oct;110(10):1586-1598. doi: 10.1007/s00392-021-01854-7. Epub 2021 Jun 22. Clin Res Cardiol. 2021. PMID: 34156521 Free PMC article. Clinical Trial.
Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.
Coughlan JJ, Aytekin A, Koch T, Wiebe J, Lenz T, Cassese S, Joner M, Koppara T, Xhepa E, Ibrahim T, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A, Kufner S. Coughlan JJ, et al. Among authors: lenz t. Catheter Cardiovasc Interv. 2022 Feb;99(3):541-551. doi: 10.1002/ccd.29944. Epub 2021 Sep 6. Catheter Cardiovasc Interv. 2022. PMID: 34487415 Clinical Trial.
Histopathology-Based Deep-Learning Predicts Atherosclerotic Lesions in Intravascular Imaging.
Holmberg O, Lenz T, Koch V, Alyagoob A, Utsch L, Rank A, Sabic E, Seguchi M, Xhepa E, Kufner S, Cassese S, Kastrati A, Marr C, Joner M, Nicol P. Holmberg O, et al. Among authors: lenz t. Front Cardiovasc Med. 2021 Dec 14;8:779807. doi: 10.3389/fcvm.2021.779807. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34970608 Free PMC article.
Target and non-target vessel related events at 10 years post percutaneous coronary intervention.
Coughlan JJ, Aytekin A, Xhepa E, Cassese S, Joner M, Koch T, Wiebe J, Lenz T, Rheude T, Pellegrini C, Gewalt S, Ibrahim T, Laugwitz KL, Schunkert H, Kastrati A, Kufner S. Coughlan JJ, et al. Among authors: lenz t. Clin Res Cardiol. 2022 Jul;111(7):787-794. doi: 10.1007/s00392-022-01986-4. Epub 2022 Feb 11. Clin Res Cardiol. 2022. PMID: 35147767 Free PMC article. Clinical Trial.
Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis.
Nano N, Aytekin A, Ndrepepa G, Seguchi M, Bresha J, Alvarez Covarrubias HA, Nicol P, Lenz T, Lahu S, Gewalt S, Voll F, Rheude T, Wiebe J, Schunkert H, Kufner S, Cassese S, Joner M, Kastrati A, Xhepa E. Nano N, et al. Among authors: lenz t. Clin Res Cardiol. 2022 Jul;111(7):827-837. doi: 10.1007/s00392-022-02024-z. Epub 2022 Apr 27. Clin Res Cardiol. 2022. PMID: 35476138 Free PMC article.
844 results